Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label, Functionality, Reliability and Performance Study of a Single-Use Auto-Injector With Home-administered Subcutaneous Benralizumab in Adult Patients With Severe Asthma (GRECO)

NCT02918071 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02918071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02918071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label, Functionality, Reliability and Performance Study of a Single-Use Auto-Injector With Home-administered Subcutaneous Benralizumab in Adult Patients With Severe Asthma (GRECO)
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
November 10, 2016
Completion date
August 21, 2017
Enrollment
121 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

asthma